Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer-Reference-Cited by-同舟云学术

Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer

Published:2008-08 Issue:2 Volume:180 Page:565-570
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Chi Kim N.¹,Chin Joseph L.¹,Winquist Eric¹,Klotz Laurence¹,Saad Fred¹,Gleave Martin E.¹

Affiliation:

1. Prostate Centre at Vancouver General Hospital, BC Cancer Agency, Vancouver Centre and the Canadian Uro-Oncology Group, Vancouver, British Columbia, the London Health Sciences Centre, London, Sunnybrook Regional Cancer Centre and Princess Margaret Hospital, Toronto, Ontario, University of Montreal, Montreal, and the Tom Baker Cancer Centre, Calgary, Alberta, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

3. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects;Gleave;J Urol,2001

4. CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group;Klotz;Urology,1999

5. Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: 3 year PSA recurrence rates;Gleave;J Urol, suppl.,2003

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy;Journal of Urology;2024-05

2. Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review;American Journal of Clinical and Experimental Urology;2024

3. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients;Journal of Robotic Surgery;2023-07-19

4. Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer;Life;2023-04-23

5. Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-05-11